The UK's serious fraud office (SFO) has opened a formal criminal investigation into GlaxoSmithKline's commercial practices.
written on 28.05.2014
The UK's serious fraud office (SFO) has opened a formal criminal investigation into GlaxoSmithKline's commercial practices.
See our Cookie Privacy Policy Here